aTyr Pharma
 (LIFE)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Nov. 10, 2015, 4:42 PM
    • aTyr Pharma (NASDAQ:LIFE): Q3 EPS of -$0.48
    | Nov. 10, 2015, 4:42 PM
  • Aug. 12, 2015, 4:31 PM
    • aTyr Pharma (NASDAQ:LIFE): Q2 EPS of -$0.74.
    | Aug. 12, 2015, 4:31 PM
  • Jun. 19, 2015, 7:37 AM
    • aTyr Pharma (LIFE) FQ1 results: Revenues: $0; R&D Expense: $6.6M (+50.0%); SG&A: $2.3M (+53.3%); Operating Loss: ($8.9M) (-50.8%); Net Loss: ($9.1M) (-49.2%); Loss Per Share: ($9.39) (-19.3%); Quick Assets: $54.5M (+242.8%).
    • No guidance given.
    | Jun. 19, 2015, 7:37 AM
  • Jun. 18, 2015, 4:26 PM
    • aTyr Pharma (Pending:LIFE): FQ1 EPS of -$9.39 vs. -$7.87 in Q114
    | Jun. 18, 2015, 4:26 PM
Company Description
aTyr Pharma Inc is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators.
Sector: Healthcare
Industry: Biotechnology
Country: United States